A 70-year-old woman with CKD stage 3b (eGFR 35 mL/min/1.73 m²) and long-standing hypertension has persistent BP 152/88 mm Hg on maximised ACE inhibitor and thiazide-like diuretic. According to recent Canadian hypertension guidance, which additional agent is recommended as part of triple therapy for resistant hypertension?